ClinicalTrials.gg
Not yet recruitingNCT07464795Updated Mar 11, 2026

The Effects of Kinesio Taping on Heel-Rise Endurance and Gastrocnemius Muscle Oxygenation in Healthy Young Adults

An interventional study of Kinesio Taping and Sham Taping in Endurance Calf Test and KINESIOTAPING, sponsored by Trakya University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by Trakya University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

acilitative kinesio taping (KT) is commonly used by athletes to support muscle performance and delay fatigue. However, evidence regarding its effects on muscle endurance and oxygenation remains inconsistent. This study aims to investigate the acute effects of facilitative KT applied to the gastrocnemius muscle on heel-rise endurance performance and local muscle oxygenation in healthy young adults.

In this randomized crossover trial, participants will complete two experimental sessions: one with facilitative kinesio taping and one with sham taping. After taping application, participants will perform a single-leg heel-rise test to task failure. Muscle oxygenation will be continuously monitored using a portable near-infrared spectroscopy device. The findings of this study may contribute to understanding whether kinesio taping has immediate physiological and performance-related effects on calf muscle endurance.

02

Conditions studied

  • Endurance Calf Test
  • KINESIOTAPING
03

In context

Lead sponsor

Trakya University is the lead sponsor of 155 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Young adults aged 18-25 years
  • Cumberland Ankle Instability Tool score of ≥28

Exclusion criteria

Exclusion Criteria:

  • Sedentary (\<150 min/week moderate or \<75 min/week vigorous physical activity)
  • Elite athletes
  • History of ankle sprain
  • Lower extremity fracture
  • Surgical intervention
  • Neurological or vestibular disorders
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Facilitative Kinesio Taping

    Participants will receive facilitative kinesio taping applied to the gastrocnemius muscle using a Y-shaped elastic tape with approximately 50% stretch. After application, participants will perform a single-leg heel-rise test to task failure.

    Device: Kinesio Taping

  • Sham comparator
    Sham Taping

    Participants will receive sham taping applied to the gastrocnemius muscle using a Y-shaped non-elastic tape without stretch. After application, participants will perform a single-leg heel-rise test to task failure.

    Device: Sham Taping

Interventions

  • DeviceKinesio Taping

    Y-shaped Kinesio Tex elastic tape applied to the gastrocnemius muscle with approximately 50% stretch following muscle facilitation principles.

  • DeviceSham Taping

    Y-shaped Hypafix tape applied to the gastrocnemius muscle without stretch using the same anatomical configuration.

06

What researchers measure

Primary outcomes

  1. Total Concentric Work (J)

    Total concentric (positive) mechanical work (Joules) performed during a metronome-guided single-leg heel-rise test to task failure on the dominant limb. Work output will be measured using the Calf Raise App (computer-vision-based motion analysis).

    Time frame: Measured during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

  2. Percent Change in Gastrocnemius Muscle Oxygen Saturation at 20 Seconds (%ΔSmO₂_20s)

    Time frame: From baseline rest to 20 seconds during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

Secondary outcomes

  1. Total number of single-leg heel-rise repetitions

    Time frame: Measured during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

  2. Peak Heel-Rise Height (cm)

    Maximum heel-rise height (cm) achieved during the single-leg heel-rise test, measured using the Calf Raise App.

    Time frame: Measured during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

  3. Concentric Power (W)

    Mean concentric power output (Watts) generated during the single-leg heel-rise test, measured using the Calf Raise App.

    Time frame: Measured during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

  4. End-Exercise Muscle Oxygen Saturation (SmO₂_end)

    Muscle oxygen saturation (SmO₂) value recorded at the point of task failure during the heel-rise test.

    Time frame: Measured at task failure during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

  5. Half-Recovery Time (HRT) of SmO₂

    Time (seconds) required for muscle oxygen saturation (SmO₂) to recover to 50% of the difference between end-exercise SmO₂ and peak recovery SmO₂ during the standardized 4-minute recovery period.

    Time frame: Measured during the 4-minute post-exercise recovery period following the heel-rise test in each experimental session (Day 1 and Day 2)

  6. Percent Change in Total Hemoglobin at 20 Seconds (%ΔtHb_20s)

    Percentage change in total hemoglobin (tHb) at 20 seconds of the heel-rise test relative to baseline (tHb\_rest), measured using near-infrared spectroscopy.

    Time frame: From baseline rest to 20 seconds during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

  7. Eccentric Work (J) During Single-Leg Heel-Rise Test

    Total eccentric (negative) mechanical work (Joules) performed during the metronome-guided single-leg heel-rise test to task failure on the dominant limb, measured using the Calf Raise App.

    Time frame: Measured during the single-leg heel-rise test in each experimental session (Day 1 and Day 2)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Oct 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2026
First posted
Mar 11, 2026
StartEst.
Apr 1, 2026
Primary completionEst.
Oct 1, 2026
CompletionEst.
Oct 1, 2026
Last update
Mar 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07464795
Lead sponsor
Trakya University
Responsible party
Muhammed Şeref Yıldırım (Research Assistant (PhD), Trakya University) — Principal investigator
First posted
Mar 11, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Mar 11, 2026

Study contacts

Muhammed Şeref Yıldırım, PhD
Contact
muhammeds.yildirim@gmail.com
+905057443650

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion